Dangerous Diagnostics And Their Social Consequences

The hope is to discover clues to these conditions before symptoms appear. The goal is to detect susceptible individuals--those who are "at risk." Reflecting the growing focus on the hereditary basis of disease, genetic testing is becoming a part of general medical practice--so much so that, in 1992, the American Medical Association recognized medical genetics as a separate subspecialty of internal medicine. Scientists should be awa

Written byDorothy Nelkin
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The hope is to discover clues to these conditions before symptoms appear. The goal is to detect susceptible individuals--those who are "at risk." Reflecting the growing focus on the hereditary basis of disease, genetic testing is becoming a part of general medical practice--so much so that, in 1992, the American Medical Association recognized medical genetics as a separate subspecialty of internal medicine.

Scientists should be aware of the potential abuses of the predictive information generated by their research and how such information is influencing social policy. The significance of this information in the 1990s stems from the current social and political climate--the increasing sense of crisis over the cost of health-care services, the prevalence of criminal violence, and the general state of the economy. In the field of health care, the Clinton administration has proposed reforms that call for cost containment and a rational distribution of benefits through changes in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies